StudyFinder



Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

Phase II, Single Arm, Non-randomized Study of Alpelisib (BYL719) in Combination with Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer Big Ten Cancer Research Consortium BTCRC-BRE19-409

A Phase II, Single Arm, Non-randomized Study of Alpelisib (BYL719) in Combination with Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer

We are asking you to take part in this voluntary research study because you have breast cancer that is estrogen and progesterone receptor positive and is HER2 receptor negative. Your breast cancer also spread outside your breast (metastatic) to other areas of your body. We are asking you to take part in this research study because your cancer has a genetic mutation in a pathway called PI3K and your tumor progressed while you were receiving hormone therapy.

Cristina Truica
PSCI-CTO@pennstatehealth.psu.edu 717-531-5471
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT04762979
STUDY00017417
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Men and postmenopausal female patients. Premenopausal patients (age 18 or older) who have been rendered postmenopausal will also be included.
Confirmed metastatic or unresectable breast cancer.
Has confirmed HER2 negative breast cancer.

Exclusion Criteria:
Patients with prior chemotherapy for metastatic or advanced disease
Treatment with any investigational drug within 14 days prior to registration.
Currently documented clinically active pneumonitis.
History of acute pancreatitis within 1 year of screening
Cancer
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,